Skin Reactions Related to Thoracic Implantable Chamber Dressings

NCT07158879 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2025-09-08

No results posted yet for this study

Summary

Prospective, multicenter cohort of 500 patients newly treated with systemic chemotherapy with CCI. The main objective of this study is to measure the incidence of skin reactions related to thoracic implantable chamber dressings.

Conditions

  • Skin Diseases

Sponsors & Collaborators

  • Institut Curie

    lead OTHER

Principal Investigators

  • Betty LIMIER · Institut Curie

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-10
Primary Completion
2026-12-10
Completion
2026-12-10

Countries

  • France
  • French Polynesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07158879 on ClinicalTrials.gov